September 13, 2024

Méthadone comparée à la buprénorphine

AKAlison KnopfUniversity of Southern California

Key Points

Key points are not available for this paper at this time.

Abstract

Les deux médicaments sont des substances contrôlées et sont approuvés pour traiter le trouble lié à l'utilisation d'opioïdes. Les OTP fournissent les deux ainsi que l'antagoniste opioïde naltrexone. Ce sont les seules médicaments approuvés pour traiter le TLU.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Alison Knopf (ven,) a étudié cette question.

synapsesocial.com/papers/68e58a60b6db6435875266ca https://doi.org/https://doi.org/10.1002/adaw.34250

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients2024 · 11 citations
2WHO updates rules calling for methadone or buprenorphine for OUD2026
3Differential Impacts of Methadone and Buprenorphine/Naloxone on Pain‐Related Outcomes Among People With Non‐Heroin Opioid Use Disorder: Secondary Analyses From a Pragmatic Canadian Multisite Trial2026
4Post-operative pain control in patients on buprenorphine or methadone for opioid use disorder2024 · 4 citations
5Methadone or buprenorphine preferred over naltrexone by inmates2024

Demander à l'IA

Bookmark

View Full Paper